| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/29/2009 | CN101417970A Dihydropyrrole derivates and method for preparing intermediate pyrrolidine |
| 04/29/2009 | CN101417969A Cinnamoyl pyrrolidine derivates and preparation method and use thereof |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/29/2009 | CN100482636C Process for preparation of substituted octanoyl amides |
| 04/29/2009 | CN100482635C Noval compounds, their use and preparation |
| 04/29/2009 | CN100482282C High water-soluble prodrug, and its preparing method and pharmaceutical use |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524980 Vitamin D3 lactam derivative |
| 04/28/2009 | US7524971 1,5-diarylpyrrole derivatives, preparation method thereof and application of same in therapeutics |
| 04/28/2009 | US7524912 Preparation of linear ethylene-acrylate copolymers with palladium catalysts and free radical scavengers |
| 04/28/2009 | US7524880 Napadisylate salt formation of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide in an aqueous isopropanol or ethanol solution; chronic obstructive pulmonary disorder, asthma; muscarinic receptor antagonists |
| 04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524821 Scaffolded maleimide clusters for multivalent peptide assembly |
| 04/28/2009 | CA2380074C Novel amide derivatives |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052068A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009052062A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051910A1 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 04/23/2009 | WO2009051718A2 Calcium receptor modulating agents |
| 04/23/2009 | WO2009051517A1 Pharmaceutical composition in the form of microcapsulated multicomponent particles made of n-carbfmoyl-methyl-4-phenyl-2-pyrrolidone and an auxiliary neutral organic low-molecular component and method for microcapsulation thereof |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051216A1 Process for stereoselective production of optically active pyrrolyl-succinic acid imide derivative |
| 04/23/2009 | WO2009050735A1 A novel polymorph of levetiracetam and a process for its preparation |
| 04/23/2009 | WO2008095069A3 High stability polyionic liquid salts |
| 04/23/2009 | WO2008053312A3 Process for preparing amorphous atorvastatin hemi calcium salt and its intermediate |
| 04/23/2009 | US20090105328 Amino Acid Compounds |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105091 Modified Amino Acids |
| 04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 04/23/2009 | US20090101514 Electrodeposition Method for Metals |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2701792A1 Calcium receptor modulating agents |
| 04/22/2009 | EP2050736A1 Imidazole derivatives, processes for preparing them and their uses |
| 04/22/2009 | EP2050735A1 Method for production of optically active 3-amino-nitrogenated compound |
| 04/22/2009 | EP2049479A2 Polymorphs of atorvastatin sodium and magnesium salts |
| 04/22/2009 | EP2049478A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 04/22/2009 | EP2049477A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 04/22/2009 | EP2049476A1 Process for the preparation of levetiracetam |
| 04/22/2009 | EP2049475A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/22/2009 | EP2049474A2 Hepatitis c virus inhibitors |
| 04/22/2009 | EP2049473A2 Substituted benzyl amine compounds |
| 04/22/2009 | EP2049472A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 04/22/2009 | EP2049104A2 Pyrrolidinone anilines as progesterone receptor modulators |
| 04/22/2009 | EP2049103A2 Inhibitors of undecaprenyl pyrophosphate synthase |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415676A N-tert-butoxycarbonyl-2-pyrrolidinone compounds and method for producing the same |
| 04/22/2009 | CN101415675A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN101415673A Process for the preparation of an N-alkyl lactam with improved colour quality |
| 04/22/2009 | CN101412711A Carbamate derivatives and use thereof in medicine |
| 04/22/2009 | CN100480239C Method for synthesizing N-hydroxy thiosuccinimide salt |
| 04/22/2009 | CN100479860C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/22/2009 | CN100479824C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 04/21/2009 | US7521584 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 04/21/2009 | US7521552 Process for preparation of substituted amino alcohols |
| 04/21/2009 | US7521470 Factor Xa inhibitors |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/16/2009 | WO2009047568A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 04/16/2009 | WO2009024823A3 Cyclopropyl amide derivatives |
| 04/16/2009 | WO2009020234A3 Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 04/16/2009 | WO2008142250A3 Process for preparing porphyrin derivatives, such as protoporphyrin (ix) and synthesis intermediate |
| 04/16/2009 | WO2006067795A3 Novel polymorphic forms of atorvastatin lactone and process for preparing the same |
| 04/16/2009 | US20090099371 Process for the preparation of amorphous atorvastatin calcium salt |
| 04/16/2009 | US20090099333 Odor-less during hydrolytic deblocking, separation; for use as source for aldehydes; crosslinking agents |
| 04/16/2009 | US20090099242 Heterocyclic inhibitors of necroptosis |
| 04/16/2009 | US20090099192 Substituted 1H-pyrrole-2,5-diones |
| 04/16/2009 | US20090099187 Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor |
| 04/16/2009 | US20090099182 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090098076 Method For the Production of a Keratin-Binding Effector Molecule |
| 04/16/2009 | DE102007049039A1 Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung Process for the preparation of 8-hydrazino-8-aryl-Octanoylderivaten and their use |
| 04/16/2009 | CA2702182A1 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells |
| 04/15/2009 | EP2046779A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/15/2009 | EP2046738A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation |
| 04/15/2009 | EP1763497B1 Method for producing alkenes by the elimination of water from alcohols, using alkylphosphonic acid anhydrides |
| 04/15/2009 | EP1720550B1 Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 04/15/2009 | EP1572631B1 Organic activator |
| 04/15/2009 | CN101410372A Novel lactams |
| 04/15/2009 | CN101410368A Viral polymerase inhibitors |
| 04/15/2009 | CN101407488A Chemical synthesis method of pyroglutamic acid alcohol and intermediates thereof |
| 04/15/2009 | CN101407487A Method for preparing racemate of R or S-1-substituent-3-amino pyrrolidine from R or S-1-substituent-3-amino pyrrolidine |
| 04/15/2009 | CN100478340C Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 04/15/2009 | CN100478339C 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517879 Pyrrolidine derivatives as factor Xa inhibitors |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2380980C Mutilin derivatives and their use as antibacterials |
| 04/09/2009 | WO2009044007A2 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | WO2009043986A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
| 04/09/2009 | WO2009043884A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors |
| 04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |